Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🤖 ML Fraud Detection Score: 86%
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,931
Total Claims
$989K
Drug Cost
639
Beneficiaries
$1,548
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+24%
Opioid rate vs peers
3.2% vs 2.6% avg
+45%
Cost per patient vs peers
$1,548 vs $1,068 avg
+35%
Brand preference vs peers
12.2% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
3.2%
Opioid Rate
382
Opioid Claims
$8,334
Opioid Cost
3.4%
Long-Acting Rate
Brand vs Generic
Brand: 1,435 claims · $763K
Generic: 10,366 claims · $219K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 247 | $118K |
| Insulin Glargine,hum.Rec.Anlog | 172 | $115K |
| Dulaglutide | 44 | $57K |
| Insulin Aspart | 40 | $47K |
| Rivaroxaban | 91 | $44K |
| Dapagliflozin Propanediol | 36 | $37K |
| Empagliflozin | 21 | $27K |
| Sitagliptin Phosphate | 18 | $25K |
| Insulin Detemir | 17 | $16K |
| Insulin Degludec | 23 | $15K |
| Insulin Lispro | 11 | $14K |
| Semaglutide | 12 | $13K |
| Alirocumab | 15 | $13K |
| Insulin Aspart Prot/Insuln Asp | 12 | $11K |
| Carbidopa/Levodopa | 25 | $10K |
Prescribing Profile
Patient Profile
74
Avg Age
56%
Female
1.10
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About